HAMBURG, Germany -- Adding weekly tirzepatide (Mounjaro) to basal insulin reduced HbA1c in patients with poorly controlled type 2 diabetes compared with adding three-times-daily insulin lispro, the ...

Patients may have trouble finding two different types of insulin products made by Eli Lilly. The company said it's experiencing a shortage of its 10 mL vials of Humalog and Insulin Lispro Injection ...

Eli Lilly and Co. LLY is phasing out select insulin products across parts of Europe for commercial reasons, with regulators ...

HAMBURG, Germany ― Once-weekly tirzepatide (Mounjaro, Lilly) added to insulin glargine resulted in greater reductions in A1c along with more weight loss and less hypoglycemia compared with prandial ...

Eli Lilly announced Wednesday that it will cap the price of insulin for people with commercial health insurance at $35. That’s a 70% price cut, which will also reduce prices on Lilly’s non-branded ...

LYON, France--(BUSINESS WIRE)-- Regulatory News: Adocia (Paris:ADOC) (Euronext Paris: FR0011184241 – ADOC), a clinical-stage biopharmaceutical company focused on the research and development of ...

Uninsured Americans pay nearly $98 on average for a vial of Eli Lilly's generic insulin. Eli Lilly earlier this year vowed to slash the list price of its generic insulin, Lispro, from $82.42 per vial ...

GREENSBORO, N.C. — The headline reads, “Lilly cuts insulin prices by 70% and caps patient insulin out-of-pocket costs at $35 per month”. It's a great headline for millions of people. There are two ...

July 13 (Reuters) - Americans without health insurance pay an average of $98 for Eli Lilly’s generic insulin despite the company’s May 1 pledge to cut its list price to $25 per vial, according to a ...

Insulin remains one of the most important treatments for people living with diabetes. Whether someone has Type 1 diabetes or advanced Type 2 diabetes, insulin therapy helps control blood sugar levels, ...